Diabetes, fracture, and bone fragility

Ann V. Schwartz, Deborah E. Sellmeyer

Research output: Contribution to journalReview articlepeer-review

Abstract

Recent studies have added to the evidence that type 1 and type 2 diabetes are associated with increased risk of hip fracture and other fractures. More frequent falls probably account for some of this increased risk, but reduced bone strength may also play a role. Although type 1 diabetes is associated with lower bone density, those with type 2 diabetes usually have elevated bone density. Yet for both types of diabetes, bone appears to be more fragile for a given density. Diabetes can affect bone through multiple pathways - some with contradictory effects - including obesity, insulin levels, hyperglycemia, and advanced glycation end products in collagen. Treatment with thiazolidinediones may increase fracture risk, at least in older women. Clinicians need to be aware of the increased fracture risk associated with diabetes. Additional research is needed to clarify the mechanisms underlying this increased risk and the best approaches to fracture prevention.

Original languageEnglish (US)
Pages (from-to)105-111
Number of pages7
JournalCurrent Osteoporosis Reports
Volume5
Issue number3
DOIs
StatePublished - Sep 2007

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Diabetes, fracture, and bone fragility'. Together they form a unique fingerprint.

Cite this